159 related articles for article (PubMed ID: 33355185)
1. Obesity is Associated with Shorter Telomere Length in Prostate Stromal Cells in Men with Aggressive Prostate Cancer.
Joshu CE; Heaphy CM; Barber JR; Lu J; Zarinshenas R; Davis C; Han M; Lotan TL; Sfanos KS; De Marzo AM; Meeker AK; Platz EA
Cancer Prev Res (Phila); 2021 Apr; 14(4):463-470. PubMed ID: 33355185
[TBL] [Abstract][Full Text] [Related]
2. Prediagnostic Obesity and Physical Inactivity Are Associated with Shorter Telomere Length in Prostate Stromal Cells.
Joshu CE; Peskoe SB; Heaphy CM; Kenfield SA; Van Blarigan EL; Mucci LA; Giovannucci EL; Stampfer MJ; Yoon G; Lee TK; Hicks JL; De Marzo AM; Meeker AK; Platz EA
Cancer Prev Res (Phila); 2015 Aug; 8(8):737-42. PubMed ID: 25990087
[TBL] [Abstract][Full Text] [Related]
3. Prostate stromal cell telomere shortening is associated with risk of prostate cancer in the placebo arm of the Prostate Cancer Prevention Trial.
Heaphy CM; Gaonkar G; Peskoe SB; Joshu CE; De Marzo AM; Lucia MS; Goodman PJ; Lippman SM; Thompson IM; Platz EA; Meeker AK
Prostate; 2015 Aug; 75(11):1160-6. PubMed ID: 25893825
[TBL] [Abstract][Full Text] [Related]
4. Current or recent smoking is associated with more variable telomere length in prostate stromal cells and prostate cancer cells.
Joshu CE; Peskoe SB; Heaphy CM; Kenfield SA; Mucci LA; Giovannucci EL; Stampfer MJ; Yoon G; Lee TK; Hicks JL; De Marzo AM; Meeker AK; Platz EA
Prostate; 2018 Feb; 78(3):233-238. PubMed ID: 29164645
[TBL] [Abstract][Full Text] [Related]
5. Racial Difference in Prostate Cancer Cell Telomere Lengths in Men with Higher Grade Prostate Cancer: A Clue to the Racial Disparity in Prostate Cancer Outcomes.
Heaphy CM; Joshu CE; Barber JR; Davis C; Zarinshenas R; De Marzo AM; Lotan TL; Sfanos KS; Meeker AK; Platz EA
Cancer Epidemiol Biomarkers Prev; 2020 Mar; 29(3):676-680. PubMed ID: 31915143
[TBL] [Abstract][Full Text] [Related]
6. Prostate cancer cell telomere length variability and stromal cell telomere length as prognostic markers for metastasis and death.
Heaphy CM; Yoon GS; Peskoe SB; Joshu CE; Lee TK; Giovannucci E; Mucci LA; Kenfield SA; Stampfer MJ; Hicks JL; De Marzo AM; Platz EA; Meeker AK
Cancer Discov; 2013 Oct; 3(10):1130-41. PubMed ID: 23779129
[TBL] [Abstract][Full Text] [Related]
7. Obesity and prostate cancer aggressiveness among African and Caucasian Americans in a population-based study.
Su LJ; Arab L; Steck SE; Fontham ET; Schroeder JC; Bensen JT; Mohler JL
Cancer Epidemiol Biomarkers Prev; 2011 May; 20(5):844-53. PubMed ID: 21467239
[TBL] [Abstract][Full Text] [Related]
8. Race Differences in Telomere Length in Benign Prostate Biopsies and Subsequent Risk of Prostate Cancer.
Rybicki BA; Sadasivan SM; Chen Y; Loveless I; Gupta NS; Chitale DA; Williamson SR; Rundle AG; Tang DL
Cancer Epidemiol Biomarkers Prev; 2022 May; 31(5):991-998. PubMed ID: 35247880
[TBL] [Abstract][Full Text] [Related]
9. Gene expression profiling of prostate tissue identifies chromatin regulation as a potential link between obesity and lethal prostate cancer.
Ebot EM; Gerke T; Labbé DP; Sinnott JA; Zadra G; Rider JR; Tyekucheva S; Wilson KM; Kelly RS; Shui IM; Loda M; Kantoff PW; Finn S; Vander Heiden MG; Brown M; Giovannucci EL; Mucci LA
Cancer; 2017 Nov; 123(21):4130-4138. PubMed ID: 28700821
[TBL] [Abstract][Full Text] [Related]
10. Anthropometrics and prostate cancer risk.
Littman AJ; White E; Kristal AR
Am J Epidemiol; 2007 Jun; 165(11):1271-9. PubMed ID: 17395597
[TBL] [Abstract][Full Text] [Related]
11. Telomere length as a risk factor for hereditary prostate cancer.
Hurwitz LM; Heaphy CM; Joshu CE; Isaacs WB; Konishi Y; De Marzo AM; Isaacs SD; Wiley KE; Platz EA; Meeker AK
Prostate; 2014 Apr; 74(4):359-64. PubMed ID: 24285042
[TBL] [Abstract][Full Text] [Related]
12. The prostate tissue-based telomere biomarker as a prognostic tool for metastasis and death from prostate cancer after prostatectomy.
Heaphy CM; Joshu CE; Barber JR; Davis C; Lu J; Zarinshenas R; Giovannucci E; Mucci LA; Stampfer MJ; Han M; De Marzo AM; Lotan TL; Platz EA; Meeker AK
J Pathol Clin Res; 2022 Sep; 8(5):481-491. PubMed ID: 35836303
[TBL] [Abstract][Full Text] [Related]
13. The association between leukocyte telomere length and cigarette smoking, dietary and physical variables, and risk of prostate cancer.
Mirabello L; Huang WY; Wong JY; Chatterjee N; Reding D; Crawford ED; De Vivo I; Hayes RB; Savage SA
Aging Cell; 2009 Aug; 8(4):405-13. PubMed ID: 19493248
[TBL] [Abstract][Full Text] [Related]
14. Leukocyte telomere length is associated with aggressive prostate cancer in localized prostate cancer patients.
Xu J; Chang WS; Tsai CW; Bau DT; Xu Y; Davis JW; Thompson TC; Logothetis CJ; Gu J
EBioMedicine; 2020 Feb; 52():102616. PubMed ID: 31981976
[TBL] [Abstract][Full Text] [Related]
15. Obesity is associated with castration-resistant disease and metastasis in men treated with androgen deprivation therapy after radical prostatectomy: results from the SEARCH database.
Keto CJ; Aronson WJ; Terris MK; Presti JC; Kane CJ; Amling CL; Freedland SJ
BJU Int; 2012 Aug; 110(4):492-8. PubMed ID: 22094083
[TBL] [Abstract][Full Text] [Related]
16. Body mass index as a predictor of prostate cancer: development versus detection on biopsy.
Freedland SJ; Terris MK; Platz EA; Presti JC
Urology; 2005 Jul; 66(1):108-13. PubMed ID: 15992911
[TBL] [Abstract][Full Text] [Related]
17. Racial differences in adipose tissue distribution and risk of aggressive prostate cancer among men undergoing radiotherapy.
Allott EH; Howard LE; Song HJ; Sourbeer KN; Koontz BF; Salama JK; Freedland SJ
Cancer Epidemiol Biomarkers Prev; 2014 Nov; 23(11):2404-12. PubMed ID: 25146088
[TBL] [Abstract][Full Text] [Related]
18. Prostate cancer incidence, clinical stage and survival in relation to obesity: a prospective cohort study in Denmark.
Møller H; Roswall N; Van Hemelrijck M; Larsen SB; Cuzick J; Holmberg L; Overvad K; Tjønneland A
Int J Cancer; 2015 Apr; 136(8):1940-7. PubMed ID: 25264293
[TBL] [Abstract][Full Text] [Related]
19. Body mass index is negatively associated with telomere length: a collaborative cross-sectional meta-analysis of 87 observational studies.
Gielen M; Hageman GJ; Antoniou EE; Nordfjall K; Mangino M; Balasubramanyam M; de Meyer T; Hendricks AE; Giltay EJ; Hunt SC; Nettleton JA; Salpea KD; Diaz VA; Farzaneh-Far R; Atzmon G; Harris SE; Hou L; Gilley D; Hovatta I; Kark JD; Nassar H; Kurz DJ; Mather KA; Willeit P; Zheng YL; Pavanello S; Demerath EW; Rode L; Bunout D; Steptoe A; Boardman L; Marti A; Needham B; Zheng W; Ramsey-Goldman R; Pellatt AJ; Kaprio J; Hofmann JN; Gieger C; Paolisso G; Hjelmborg JBH; Mirabello L; Seeman T; Wong J; van der Harst P; Broer L; Kronenberg F; Kollerits B; Strandberg T; Eisenberg DTA; Duggan C; Verhoeven JE; Schaakxs R; Zannolli R; Dos Reis RMR; Charchar FJ; Tomaszewski M; Mons U; Demuth I; Iglesias Molli AE; Cheng G; Krasnienkov D; D'Antono B; Kasielski M; McDonnell BJ; Ebstein RP; Sundquist K; Pare G; Chong M; Zeegers MP;
Am J Clin Nutr; 2018 Sep; 108(3):453-475. PubMed ID: 30535086
[TBL] [Abstract][Full Text] [Related]
20. Circulating leukocyte telomere length and risk of overall and aggressive prostate cancer.
Julin B; Shui I; Heaphy CM; Joshu CE; Meeker AK; Giovannucci E; De Vivo I; Platz EA
Br J Cancer; 2015 Feb; 112(4):769-76. PubMed ID: 25562437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
